ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,191.90
-1.23%
S&P ASX All Technology
3,746.90
-2.57%
Brent Oil
80.64
0.03%
US Dollar vs AUD
1.62868
0.23%
Bitcoin
94,216.52
-0.29%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Denali Capital Acquisition Corporation (DECA) Share Price

Denali Capital Acquisition Corporation

Denali Capital Acquisition Corporation (DECA)

NASDAQ
11.97
0.07
(0.59%)
Closed 13 January 8:00AM
Delayed by 15 minutes
11.97
0.00
(0.00%)
After Hours: 8:07AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
11.97
Bid
10.06
Offer
19.20
Volume
446
11.90 Day's Range 12.00
4.05 52 Week Range 12.25
Market Cap
60.423M
Previous Close
11.90
Open
11.90
Last Trade
1
@
11.84
Last Trade Time
Financial Volume
US$ 5,345
VWAP
11.985
Average Volume (3m)
2,908
Shares Outstanding
5,047,829
Dividend Yield
-
PE Ratio
95.45
Earnings Per Share (EPS)
0.13
Revenue
-
Net Profit
633k

About Denali Capital Acquisition Corporation

Denali Capital Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Denali Capital Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Sector
Blank Checks
Industry
Blank Checks
Headquarters
Grand Cayman, Cym
Founded
-
Denali Capital Acquisition Corporation is listed in the Blank Checks sector of the NASDAQ with ticker DECA. The last closing price for Denali Capital Acquisition was US$11.90. Over the last year, Denali Capital Acquisition shares have traded in a share price range of US$ 4.05 to US$ 12.25.

Denali Capital Acquisition currently has 5,047,829 shares in issue. The market capitalisation of Denali Capital Acquisition is US$60.07 million. Denali Capital Acquisition has a price to earnings ratio (PE ratio) of 95.45.

Ask ADVFN Intelligence (AI)

DECA Latest News

More News

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

09 January 2025
GlobeNewswire Inc.

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

12 December 2024
GlobeNewswire Inc.

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

12 November 2024
GlobeNewswire Inc.

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously

As previously announced, Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA, the “SPAC”) entered into...

07 November 2024
GlobeNewswire Inc.

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary

Scilex notified NASDAQ on October 28, 2024 that it has set a record date of November 7, 2024 (the “Record Date”) for the dividend of Scilex preferred stock to Scilex’s stockholders and certain...

28 October 2024
GlobeNewswire Inc.

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur a

Semnur is currently in discussions regarding strategic regional and/or worldwide collaborations and potential outright acquisition of SP-102. Any such transactions may have the potential to...

16 October 2024
GlobeNewswire Inc.

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) --  Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

12 October 2024
GlobeNewswire Inc.

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) --  Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account...

12 September 2024
GlobeNewswire Inc.

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination

Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: DECA, the “SPAC”) announce the...

03 September 2024
GlobeNewswire Inc.

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, , Aug. 09, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account...

10 August 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.090.75757575757611.8811.9911.88191711.89763563CS
40.110.92748735244511.8611.9911.81560211.88850957CS
120.463.9965247610811.5112.2511.34290811.79892847CS
260.655.7420494699611.3212.2511.3284211.62470442CS
525.2277.33333333336.7512.254.05175638.12254696CS
1562.0220.30150753779.9514.14.05234889.91211965CS
2602.0220.30150753779.9514.14.05234889.91211965CS

DECA - Frequently Asked Questions (FAQ)

What is the current Denali Capital Acquisition share price?
The current share price of Denali Capital Acquisition is US$ 11.97
How many Denali Capital Acquisition shares are in issue?
Denali Capital Acquisition has 5,047,829 shares in issue
What is the market cap of Denali Capital Acquisition?
The market capitalisation of Denali Capital Acquisition is USD 60.07M
What is the 1 year trading range for Denali Capital Acquisition share price?
Denali Capital Acquisition has traded in the range of US$ 4.05 to US$ 12.25 during the past year
What is the PE ratio of Denali Capital Acquisition?
The price to earnings ratio of Denali Capital Acquisition is 95.45
What is the reporting currency for Denali Capital Acquisition?
Denali Capital Acquisition reports financial results in USD
What is the latest annual profit for Denali Capital Acquisition?
The latest annual profit of Denali Capital Acquisition is USD 633k
What is the registered address of Denali Capital Acquisition?
The registered address for Denali Capital Acquisition is MAPLES CORPORATE SERVICES LIMITED, PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1-1104
Which industry sector does Denali Capital Acquisition operate in?
Denali Capital Acquisition operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

Discussion

View Full Feed
OPennyS OPennyS 7 minutes ago
If the predictions are correct it is going to be an interesting week.
VXX
Hoghead7 Hoghead7 10 minutes ago
PORTHOS still on schedule. Seems like spring/summer commissioning
https://www.linkedin.com/posts/porthos-co2_porthos-porthosco-co2-activity-7282763014376677376-qnb-?utm_source=share&utm_medium=member_android

https://www.linkedin.com/posts/activity-7275803191202447360-EX6x?utm
FCEL
mining hound mining hound 18 minutes ago
Hi all, thanks for happy new year wishes and I wish the same for all here too!
HLLXF
gfp927z gfp927z 27 minutes ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
gfp927z gfp927z 28 minutes ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
georgebailey georgebailey 28 minutes ago
Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.
NWBO
Birdbrain Ideas Birdbrain Ideas 29 minutes ago
If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b
AMRN
devil dog 96 devil dog 96 31 minutes ago
In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b
ATMH
3jack 3jack 32 minutes ago
We will persevere!
AVXL
gfp927z gfp927z 32 minutes ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
3jack 3jack 32 minutes ago
We know who you are!
AVXL
gfp927z gfp927z 33 minutes ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
Lazerator Lazerator 35 minutes ago
Not "walking dead", just dead. I just wish they'd declare bankruptcy instead of pretending like it's going to trade again.
Lazerator Lazerator 36 minutes ago
Clearly, Port turned out to be the fool. Actually, he made fools of all you guys who bought into his scam.
imho imho 37 minutes ago
In the comment section of this article,
https://seekingalpha.com/article/4748984-playing-the-odds-of-anavex-alzheimers-drug-approval#scroll_comments

Someone named Stephen Ayers in his Saturday, 12:42PM comment, says

I asked ChatGPT why the following statement, w
AVXL
Ryoko Ryoko 38 minutes ago
It's not going to be audited. They lied again. They do that once a year. Been that way for the last 4 years.
IBGR
axelvento axelvento 40 minutes ago
has announced that it will be paying its dividend of $0.43 on the 7th of March, an increased payment from last year's comparable dividend. This makes the dividend yield 6.5%, which is above the industry average

$PFE
PFE
Steady_T Steady_T 43 minutes ago
You might be correct about the size of the GBM market in the UK. However you are missing the point.

Approval in the UK validates the MOA and the potential of treating other solid cancers. That will have much more impact than the limited size of the UK market.

Approval
NWBO
skitahoe skitahoe 43 minutes ago
While I'd love you to be right, that would represent over a $14 billion market cap, I believe that's high until the EDEN is available for production of the vaccine. I just don't believe that enough vaccine can be produced in Sawston to justify that market cap until they can make more, which require
NWBO
Saving Grace Saving Grace 44 minutes ago
Putz: We are not at 2 years. Who's we? LoL SMH

Keep an eye on the door. Big revelation! It's coming. UK
NB
elks elks 44 minutes ago
Thanks.
RDAR
commdude commdude 44 minutes ago
I purchased some MJLink stocks a few years ago via their web portal. I assume they are pretty much worthless now, or????  

It wasn't a large investment, and just crossed my mind that I have them after revisiting this forum.
WDLF
TradingCharts TradingCharts 46 minutes ago
Page 2 Signed July 26, 2024

https://cases.stretto.com/public/X063/10210/PLEADINGS/1021007262480000000235.pdf
7. Stalking Horse. The Trustee has demonstrated a sound business justification for
the Court to approve (i) Meteor Energy, LLC or its designee as the Stalking
IBATF
Steady_T Steady_T 49 minutes ago
Good article with a positive slant. It did touch on the potential negatives to give some balance.

Hopefully that is enough depth to generate some interest in Anavex. He did make clear that the approval is likely to be late in the year.

At this point I see a lot of vola
AVXL

Your Recent History

NASDAQ
DECA
Denali Capital Acquisition
BIT
UR9ZPS
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads